NCT03991143View on ClinicalTrials.gov

Efficacy, Safety and Tolerability of ATH3G10 in Patients With ST-elevation Myocardial Infarction

PHASE2CompletedINTERVENTIONAL
Enrollment

82

Participants

Timeline

Start Date

March 29, 2019

Primary Completion Date

July 6, 2020

Study Completion Date

April 19, 2021

Conditions
ST Elevation Myocardial Infarction
Interventions
DRUG

ATH3G10

intravenous

DRUG

Placebo

intravenous

Trial Locations (1)

75237

Department of Cardiology, Uppsala University Hospital, Uppsala

Sponsors
All Listed Sponsors
lead

Athera Biotechnologies AB

INDUSTRY

NCT03991143 - Efficacy, Safety and Tolerability of ATH3G10 in Patients With ST-elevation Myocardial Infarction | Biotech Hunter | Biotech Hunter